Nafronyl or naftidrofuryl

This classification denotes a vasodilating agent and serotonin antagonist with the molecular formula C24H33NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42H8PQ0NMJ, chemically known as 2-furanpropionic acid, tetrahydro-.alpha.-(1-naphthylmethyl)-, 2-(diethylamino)ethyl esteroxalate (1:1) but generally known as nafronyl, which bears US NIH Compound Identifier 4417. European Medicines Agency schedules Naftidrofuryl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09130MIG. The term NAFTIDROFURYL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules nafronyl in its Anatomical Therapeutic Chemical (ATC) Classification. Nafronyl or naftidrofuryl bears US NLM identifiers UMLS ID C0027329 and NCI Concept Code C87212. SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.